115 related articles for article (PubMed ID: 10216148)
1. Modeling the hepatitis C virus epidemic in France.
Deuffic S; Buffat L; Poynard T; Valleron AJ
Hepatology; 1999 May; 29(5):1596-601. PubMed ID: 10216148
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C and hepatitis B-related mortality in Spain.
García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
[TBL] [Abstract][Full Text] [Related]
3. Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection.
Sypsa V; Touloumi G; Tassopoulos NC; Ketikoglou I; Vafiadis I; Hatzis G; Tsantoulas D; Akriviadis E; Delladetsima J; Demonakou M; Hatzakis A
J Viral Hepat; 2004 Jul; 11(4):366-74. PubMed ID: 15230860
[TBL] [Abstract][Full Text] [Related]
4. Modeling the hepatitis C virus epidemic in France using the temporal pattern of hepatocellular carcinoma deaths.
Griffiths J; Nix B
Hepatology; 2002 Mar; 35(3):709-15. PubMed ID: 11870388
[TBL] [Abstract][Full Text] [Related]
5. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.
Cacoub P; Geffray L; Rosenthal E; Perronne C; Veyssier P; Raguin G;
Clin Infect Dis; 2001 Apr; 32(8):1207-14. PubMed ID: 11283811
[TBL] [Abstract][Full Text] [Related]
6. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
Lehman EM; Wilson ML
J Viral Hepat; 2009 Sep; 16(9):650-8. PubMed ID: 19413698
[TBL] [Abstract][Full Text] [Related]
7. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
8. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections.
Deuffic-Burban S; Mohamed MK; Larouze B; Carrat F; Valleron AJ
J Hepatol; 2006 Mar; 44(3):455-61. PubMed ID: 16310281
[TBL] [Abstract][Full Text] [Related]
9. Natural histories of hepatitis C virus infection in men and women simulated by the Markov model.
Tanaka J; Kumada H; Ikeda K; Chayama K; Mizui M; Hino K; Katayama K; Kumagai J; Komiya Y; Miyakawa Y; Yoshizawa H
J Med Virol; 2003 Jul; 70(3):378-86. PubMed ID: 12767000
[TBL] [Abstract][Full Text] [Related]
10. Modelling the past, current and future HCV burden in France: detailed analysis and perspectives.
Deuffic-Burban S; Mathurin P; Valleron AJ
Stat Methods Med Res; 2009 Jun; 18(3):233-52. PubMed ID: 19036916
[TBL] [Abstract][Full Text] [Related]
11. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma and hepatitis C in the United States.
El-Serag HB
Hepatology; 2002 Nov; 36(5 Suppl 1):S74-83. PubMed ID: 12407579
[TBL] [Abstract][Full Text] [Related]
13. Regression analysis of trends in mortality from hepatocellular carcinoma in Japan, 1972-2001.
Shibuya K; Yano E
Int J Epidemiol; 2005 Apr; 34(2):397-402. PubMed ID: 15561746
[TBL] [Abstract][Full Text] [Related]
14. Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments.
Sypsa V; Touloumi G; Papatheodoridis GV; Tassopoulos NC; Ketikoglou I; Vafiadis I; Hatzis G; Tsantoulas D; Akriviadis E; Koutsounas S; Hatzakis A
J Viral Hepat; 2005 Sep; 12(5):543-50. PubMed ID: 16108772
[TBL] [Abstract][Full Text] [Related]
15. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality.
Tanaka Y; Kurbanov F; Mano S; Orito E; Vargas V; Esteban JI; Yuen MF; Lai CL; Kramvis A; Kew MC; Smuts HE; Netesov SV; Alter HJ; Mizokami M
Gastroenterology; 2006 Mar; 130(3):703-14. PubMed ID: 16530512
[TBL] [Abstract][Full Text] [Related]
16. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
[TBL] [Abstract][Full Text] [Related]
17. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.
Seeff LB; Hoofnagle JH
Oncogene; 2006 Jun; 25(27):3771-7. PubMed ID: 16799618
[TBL] [Abstract][Full Text] [Related]
20. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
